Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 104.5% in First Quarter of 2023

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 359 million yuan in the first quarter of 2023, up 104.5% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 83.3% year-on-year.

At the end of the reporting period, it had 13.5 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 13.3%.